Related Experiment Video
Updated: May 22, 2026

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Amphotericin B up-regulates lipid A-induced IL-6 production via caspase-8
R Tamai1, M Sugamata, Y Kiyoura
1Department of Oral Medical Science, Ohu University School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima 963-8611, Japan.
Abstract:
Amphotericin B, an antifungal drug used to treat candidiasis, has been reported to induce pro-inflammatory cytokine production in cultured cells. This study investigated the effects of amphotericin B on pro-inflammatory cytokine production in response to lipid A, the bioactive component of lipopolysaccharide (LPS) in the cell walls of Gram-negative bacteria. Amphotericin B alone elicited a slight increase in interleukin (IL)-6 and IL-8 production by human gingival fibroblasts. However, amphotericin B synergistically up-regulated lipid A-induced production of IL-6 and IL-8. While amphotericin B minimally activated nuclear factor (NF)-κB, it synergistically increased lipid A-induced NF-κB activation. Pre-treatment with methyl-β-cyclodextrin (MβCD), a cholesterol-binding agent, reduced IL-6 and IL-8 production in human gingival fibroblasts. Cholesterol-saturated MβCD also reversed cytokine production, suggesting that the synergistic production of cytokines by amphotericin B and lipid A is dependent on cholesterol-rich microdomains. Amphotericin B activated caspase-8. In addition, a caspase-8 inhibitor inhibited IL-6 production by amphotericin B and lipid A. This suggests that caspase-8 is required for the synergistic production of IL-6 by amphotericin B and lipid A. Collectively, our results suggest that periodontal treatment carried out before amphotericin B treatment may protect against lipid A-induced pro-inflammatory cytokine production.
Insights
Amphotericin B enhances the inflammatory response to bacterial components like lipid A. This interaction, dependent on cell membrane cholesterol, involves caspase-8 and may be mitigated by prior periodontal treatment.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Amphotericin B, an antifungal, can stimulate pro-inflammatory cytokines.
- Lipid A from Gram-negative bacteria is a potent immune activator.
Purpose of the Study:
- To investigate how amphotericin B affects lipid A-induced cytokine production.
- To explore the mechanisms underlying this synergistic effect.
Main Methods:
- Human gingival fibroblasts were treated with amphotericin B and lipid A.
- Levels of interleukin (IL)-6, IL-8, and nuclear factor (NF)-κB activation were measured.
- The role of cholesterol-rich microdomains and caspase-8 was assessed using methyl-β-cyclodextrin and inhibitors.
Main Results:
- Amphotericin B alone caused minor IL-6 and IL-8 increases.
- It synergistically amplified lipid A-induced IL-6, IL-8, and NF-κB activation.
- This synergy was dependent on cholesterol-rich microdomains and mediated by caspase-8.
Conclusions:
- Amphotericin B potentiates lipid A-induced inflammation via cholesterol-dependent pathways and caspase-8.
- Periodontal treatment before amphotericin B may offer protection against this inflammatory response.
Related Concept Videos
Antifungal Agents
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

